Navigating Global Policy Shifts: Implications for Europe’s Pharmaceutical Pricing, Market Access, and HTA Landscape

As global healthcare policies evolve in response to geopolitical and geoeconomic pressures, Europe’s pharmaceutical market faces significant challenges in pricing, market access, and health technology assessment (HTA). This symposium will delve into how major global, regional and local policy changes are reshaping Europe’s ability to provide affordable, equitable, and sustainable access to innovative therapies for patients, while maintaining its position as a competitive and attractive market for pharmaceutical investments. The session will first explore how recent and prospective U.S. policies - such as Medicare drug price negotiations, Most-Favored-Nation pricing, tariffs and pressure on other countries to increase spending on innovative medicines - could reshape European access environments, requiring new approaches from pharmaceutical companies. Next, presenters will analyse the implications of evolving pipelines and policies in China and other major markets, focusing on their approach to value-based pricing, evidence generation, and innovative contracting, and how these trends may set new benchmarks for Europe. Finally, the session will examine Europe’s own trajectory, including revision of the General Pharmaceutical Legislation, the harmonization of HTA through the joint clinical assessment and the increasing emphasis on real-world evidence (RWE), cost-effectiveness thresholds, and multi-stakeholder collaboration. These developments will be assessed in the context of their impact on pricing negotiations, access timelines, and incentives for innovation. Attendees will gain actionable insights into where global and European pricing and HTA policies are converging or diverging, what this means for market access strategies, and how policymakers can adapt to ensure equitable and sustainable patient access to innovative therapies. The session will provide a forward-looking view of how Europe can navigate these changes to maintain sustainability, become more competitive and foster innovation.

Sponsored by Corporate Partner, Cencora